Philadelphia, PA, United States of America

Adam Cohen


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adam Cohen: Innovator in Gene Cloning Technology

Introduction

Adam Cohen is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of gene cloning. His innovative work has led to the development of methods that enhance the cloning and expression of toxic genes.

Latest Patents

Adam Cohen holds a patent for an "Expression system for cloning toxic genes." This patent describes methods for cloning and amplifying toxic genes in bacteria using a vector that not only amplifies the toxic gene but also facilitates subsequent expression in mammalian systems. The vector includes an origin of replication, a first promoter, a polylinker, a second promoter in reverse orientation with respect to the first promoter, a polyadenylation signal, and a gene encoding a selectable marker. Additionally, it may include an enhancer operably connected to the first promoter and/or a nucleotide sequence encoding a toxic protein.

Career Highlights

Adam Cohen is affiliated with the University of Pennsylvania, where he continues to advance research in biotechnology. His work has garnered attention for its potential applications in various fields, including medicine and genetic engineering.

Collaborations

Some of his notable coworkers include David B. Weiner and Donghui Zhang, who have collaborated with him on various research projects.

Conclusion

Adam Cohen's innovative contributions to gene cloning technology highlight his role as a leading inventor in the biotechnology sector. His work continues to influence advancements in the field and offers promising avenues for future research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…